1. (a) Pursuant to RSA 265-A:40, II(g), the IDCMP shall be responsible for the administration of drug and alcohol testing required by the court or included in the service plan.
2. (b) An IDCMP shall administer drug or alcohol testing by requiring that sample collection and testing be conducted at a Clinical Laboratory Improvement Amendments (CLIA)-approved testing laboratory or may administer on-site rapid drug or breathalyzer tests, if there is reasonably suspicion that the client is impaired, or if there is another clinical justification to do so.
3. (c) An IDCMP shall not require drug or alcohol testing to be conducted by an IDSP.

4. (d) The following types of drug or alcohol testing may be included in a client’s service plan:

   1. (1) Any testing required by the sentencing court; and
   2. (2) Testing of a client’s urine or BAC, if clinically indicated.
5. (e) A service plan shall not require testing of a client’s blood unless required by the sentencing court.
6. (f) The frequency of alcohol or drug testing required by the service plan, except for testing required by the sentencing court, shall be no more than once per month, except that a second test may be ordered in a month if the test comes back positive.
7. (g) If a client refuses a drug or breathalyzer test or does not show up for a drug or breathalyzer test within the required time frame, it shall be treated as a positive test.
8. (h) If a client has a positive drug or breathalyzer test, the IDCMP and the IDSP shall review the service plan and determine if further counseling, or case management, or both is clinically indicated.
9. (i) Clients shall be responsible for the cost of sample collection and testing done at an outside testing site and for any rapid tests conducted on-site.
10. (j) There shall be no conflict of interest between an IDCMP and an outside testing site.

Source. #10240, eff 1-1-13; ss by #13846, eff 1-6-24, EXPIRES: 1-6-34